Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF OCTOBER 31, 2002 FBO #0333
SOLICITATION NOTICE

A -- Developing BMS247550 in the study of cervical cancer

Notice Date
10/29/2002
 
Notice Type
Solicitation Notice
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Research Contracts Br., 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
 
ZIP Code
20852
 
Solicitation Number
Reference-Number-NCI-30007-NV
 
Archive Date
11/21/2002
 
Point of Contact
Deborah Moore, Purchasing Agent, Phone (301) 402-4509, Fax (301) 402-4513, - David Keefer, Contracting Officer, Phone (301) 435-3801, Fax (301) 480-0309,
 
E-Mail Address
dm170b@nih.gov, dk63h@nih.gov
 
Description
The National Cancer Institute (NCI), Divisional of Clinical Sciences, Experimental Therapeutics Section plans to enter into a sole source contract with Marianne Porchynsky, Ph.D., Potomac, MD 20854. This procurement will provide continued technical support of studies using novel epothilone analog (BMS247550) developed by Bristole Meyes Squibb in patients with cervical cancer. The Experimental Therapeutics Section entered in to a CRADA with Bristol Meyes Squibb which has been underway for several years for the study of BMS247550. Dr. Poruchynsky will be responsible for: 1) extraction of RNA from small tissue samples; 2) extraction of protein from small tissue samples; 3) performance of western blot analyses; 4) performance of northern blot analyses; and 5) performance of assays to assess the extent of tubulin polymerization in peripheral mononuclear samples. Dr. Marianne Porchynsky has more than 20 years of research experience related to this trial and for the past several years has been associated with this study which makes her uniquely qualified to continue with this clinical trial. This is not a request for competitive quotation. However, if any interested party believes it can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities and any other information furnished must be in writing and must contain material in sufficient detail to allow the NCI research to determine if the party can perform this requirement. An original and one copy of the capability statements must be received in the contracting office by 1:00 p.m. EDT, on November 6, 2002. All questions must be in writing and can be faxed to (301) 402-4513 or emailed to dm170b@nih.gov . It is the vendor's responsibility to call (301) 402-4509 to insure questions have been received. A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect call will be accepted.
 
Place of Performance
Address: 9000 Rockville Pike, Bethesda, MD
Zip Code: 20892
 
Record
SN00195512-W 20021031/021029213217 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.